Health
A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines – News-Medical.net
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the adv…
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the advance of such platforms in the pursuit for the effective vaccine. Their results are currently available on bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent of the ongoing COVID-19 pa…
-
Noosa News16 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business21 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General22 hours agoRush to buy homes before rate cuts send prices soaring
-
Business19 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025